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Abstract
Background: The fruit bat species Rousettus aegyptiacus was identified as a potential reservoir for the highly pathogenic
filovirus Marburg virus. To establish a basis for a molecular understanding of the biology of filoviruses in the reservoir host,
we have adapted a set of molecular tools for investigation of filovirus replication in a recently developed cell line, R06E,
derived from the species Rousettus aegyptiacus.
Methodology/Principal Findings: Upon infection with Ebola or Marburg viruses, R06E cells produced viral titers comparable
to VeroE6 cells, as shown by TCID50 analysis. Electron microscopic analysis of infected cells revealed morphological signs of
filovirus infection as described for human- and monkey-derived cell lines. Using R06E cells, we detected an unusually high
amount of intracellular viral proteins, which correlated with the accumulation of high numbers of filoviral nucleocapsids in
the cytoplasm. We established protocols to produce Marburg infectious virus-like particles from R06E cells, which were then
used to infect naı ¨ve target cells to investigate primary transcription. This was not possible with other cell lines previously
tested. Moreover, we established protocols to reliably rescue recombinant Marburg viruses from R06E cells.
Conclusion/Significance: These data indicated that R06E cells are highly suitable to investigate the biology of filoviruses in
cells derived from their presumed reservoir.
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Introduction
Bats have been shown to be hosts for many pathogens, including
those causing tropical diseases, such as leptospira, Hendra virus,
Nipah virus and SARS-like coronavirus [1–6]. In some cases the
development of disease in humans has been directly linked to
contact with infected bats. Recently, several species of fruit bats
were identified as probable reservoirs for the filoviruses Marburg
virus (MARV) and Ebola virus (EBOV) [7–11]. Filoviruses cause a
severe hemorrhagic fever with case fatality rates of up to 90%, for
which there is neither an approved vaccine nor specific treatment
currently available [12]. As a result of this, as well as the fact that
filoviruses represent a serious hazard for laboratory workers, they
are classified as biosafety level 4 (BSL4) agents. The filovirus
outbreaks in Central Africa occur sporadically and unpredictably,
the latter contributes considerably to the public awareness of
filovirus outbreaks. For more than 40 years the search for the
natural reservoir of filoviruses was one of the most interesting
endeavours in the field of highly pathogenic agents, and was fuelled
by the dramatic outbreaks, cases of filovirus infected tourists and
concerns that filoviruses might be abused as biological weapons.
In the case of EBOV, outbreaks could frequently be traced back
to the preparation of bush meat, often from sick monkeys, for
consumption [13,14]. Since filovirus infection of monkeys results
in a rapid and fatal hemorrhagic fever, it was considered that
monkeys do not represent the natural reservoir of EBOV or
MARV. Right from the beginning of the recorded history of
filovirus outbreaks, the MARV outbreak in 1967, it was suspected
that bats might also be connected to the spread of infection. This
was emphasized by the observation that, in those cases where the
consumption of contaminated bush meat could be ruled out as the
source of infection, often a close contact between index cases and
bats was observed [15]. In 1996, Swanepoel et al. were able to
show that certain species of bats could be productively infected
with EBOV without showing signs of disease, which was
considered a prerequisite for serving as natural hosts [16].
Supporting this hypothesis, filoviral genomic RNA and antibodies
could be detected in bats of different species from the region where
outbreaks had occurred, providing the first evidence that bats are
infected in a natural context [8,11]. Finally, while MARV was
isolated from samples of the Megachiropteran Rousettus aegyptiacus
that were trapped in regions where outbreaks took place [15] the
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for EBOV is based on serologic data [9].
The filoviruses EBOV and MARV are enveloped RNA viruses
with a filamentous shape and constitute the family Filoviridae within
the order Mononegavirales. The family of Filoviridae contains the
genera Marburgvirus and Ebolavirus [12]. Filoviruses contain a non-
segmented negative-strand 19 kb RNA genome, which encodes
seven structural proteins and an additional nonstructural protein
in the case of Ebola virus. The genome is associated with four
nucleocapsid proteins: NP, VP30, VP35 and L [17]. NP
encapsidates the viral genome and is, together with the polymerase
L and the polymerase cofactor VP35, necessary and sufficient for
viral replication. VP30, the fourth nucleocapsid protein, represents
an essential transcription factor for Ebola virus [18–20]. The
filoviral nucleocapsid is enclosed by two matrix proteins, VP40
and VP24 that connect the nucleocapsid with the lipid envelope
[17]. The transmembrane glycoprotein GP is inserted in the
envelope, where it recognizes target cells and induces fusion
between cellular and viral membranes [21–23].
So far, little is known about the filoviral life cycle in the
presumed reservoir. One study describes persistent infection of a
Mexican free-tailed bat cell line Tb1.Lu with EBOV. The authors
showed that EBOV replication in these cells was low but could be
stimulated by inducing the Ras/MAPK pathway [24]. The
Mexican free-tailed bat belongs to the order Microchiroptera
and is abundant in North America but is only very distantly
related to Megachiroptera such as Rousettus aegyptiacus, the
presumed natural reservoir of filoviruses. The unavailability of a
cell line from a bat species that is relevant for filovirus transmission
to humans constrains research of filovirus biology in the natural
reservoir. Recently, Jordan et al. presented a newly established cell
line derived from Rousettus aegyptiacus (R06E), which could
presumably close this gap by allowing in vitro studies to understand
the replication of filoviruses in bats [25]. So far, filoviruses have
been propagated in human or monkey cell lines and it was now of
interest to determine whether cells from the natural host replicate
filoviruses, and if so to characterize the infection. Here we have
examined whether the R06E cell line is suitable for investigations
of filovirus infection.
Methods
Cell culture and virus infection
VeroE6 (African green monkey kidney cells), HEK293 (human
embryonic kidney cells), HUH7 (human hepatoma cells) and
R06E cells (derived from Rousettus aegyptiacus) [25] were cultured in
Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% fetal calf serum (FCS), penicillin (50 units/mL), and
streptomycin (50 mg/mL). The Leiden strain of MARV, which
was isolated in 2008 from a tourist visiting a bat-infested cave in
Uganda [26], or the Mayinga strain of Zaire ebolavirus (ZEBOV)
(GenBank accession number NC002549) were propagated in
VeroE6 cells. Virus titers were determined by 50% tissue culture
infectious dose (TCID50) assays. Cells were infected with MARV
or ZEBOV with 0.1, 0.5 or 5 TCID50/ml per cell, as indicated. All
work with filoviruses was performed in the biosafety level 4 (BSL4)
facility of the Philipps University, Marburg.
TCID50 assay
VeroE6 cells were cultured in 96-well plates to 50% confluence
and infected with 10-fold serial dilutions of supernatants from
infected cells. At 10 to 14 days post infection (p.i.), when the
cytopathic effect had stabilized, cells were analyzed by light
microscopy. The TCID50/ml was calculated using the Spearman-
Ka ¨rber method [27].
Electron microscopy
Infected cells were fixed 2 or 3 days p.i. in paraformaldehyde
(PFA) and glutaraldehyde (4% PFA, 0.1% glutaraldehyde in
60 mM Pipes, 25 mM Hepes, 2 mM MgCl2, 10 mM EGTA,
pH 7.0), scraped off after 30 minutes and centrifuged at 20,0006g
for 20–30 minutes. The fixative solution was replaced with 4%
PFA in DMEM to completely inactivate the sample overnight
before removal from the BSL4 laboratory. Dehydration of infected
cells and embedding in Epon were performed as described
previously [28]. Ultrathin sections were stained with uranyl acetate
and lead citrate and observed with a Zeiss 109 electron
microscope. Supernatants of the infected cells were centrifuged
through a 20% sucrose cushion at 77,0006ga t4 uC to concentrate
the viral particles. The pellet was inactivated and fixed with 4%
PFA in DMEM overnight. Negative staining of viral suspensions
was done with 2% phosphotungstic acid.
Minigenome and iVLP assay
Cells were transfected with plasmids encoding a MARV
minigenome (3M–5M-Luc, 1 mg) [20,29,30] and the viral proteins
necessary for replication and transcription: NP (0.1 mg), VP35
(0.5 mg), VP30 (0.1 mg), and the polymerase L (1 mg) using
TransIT-LT1 (Mirus, Madison, WI, USA) according to the
manufacturer’s instructions. The minigenome contained a renilla
luciferase reporter gene instead of the CAT gene [30,31]. In
addition, a plasmid coding for the T7 polymerase (0.5 mg) and a
construct constitutively expressing a firefly luciferase reporter
(pGL4, Promega, 0.1 mg), suitable for normalization of transfec-
tion efficiency, were co-transfected. At 48 h post transfection (p.t.),
cells were lysed in passive lysis buffer (Promega, Madison, WI,
USA). Luciferase assays were performed using the Promega Dual-
Luciferase reporter assay system. Relative firefly luciferase signals
were used to normalize for transfection efficiency.
The MARV iVLP assay was performed as described by
Wenigenrath et al. [30]. At 48 h p.t., cells and supernatants were
harvested. iVLPs from the supernatant were used to infect cells
that were either untreated or pretransfected with plasmids
Author Summary
Marburg virus and several species of Ebola virus are
endemic in central Africa and cause sporadic outbreaks in
this region with mortality rates of up to 90%. So far, there
is no vaccination or therapy available to protect people at
risk in these regions. Recently, different fruit bats have
been identified as potential reservoirs. One of them is
Rousettus aegyptiacus. It seems that within huge bat
populations only relatively small numbers are positive for
filovirus-specific antibodies or filoviral RNA, a phenomenon
that is currently not understood. As a first step towards
understanding the biology of filoviruses in bats, we sought
to establish a model system to investigate filovirus
replication in cells derived from their natural reservoir.
Here, we provide the first insights into this topic by
monitoring filovirus infection of a Rousettus aegyptiacus
derived cell line, R06E. We were able to show that
filoviruses propagate well in R06E cells, which can,
therefore, be used to investigate replication and transcrip-
tion of filovirus RNA and to very efficiently perform rescue
of recombinant Marburg virus using reverse genetics.
These results emphasize the suitability of the newly
established bat cell line for filovirus research.
Filovirus Infection of Fruit Bat Cells
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or 72 h p.i. for luciferase reporter activity.
Student’s t test was performed to analyze statistical significances
within the different in vitro assays.
Western blot analysis
Whole-cell extracts were prepared by lysing cells in sodium
docecyl sulfate (SDS) sample buffer (25% glycerol, 2.5% SDS,
125 mM Tris [pH 6.8], 125 mM dithiothreitol, 0.25% bromo-
phenol blue). Samples were boiled for 10 minutes at 99uC and
transferred into a fresh tube before removal from the BSL4 facility.
Proteins were separated on 12% SDS polyacrylamide gels and
transferred onto polyvinylidene difluoride membranes. Immuno-
staining was performed with dilutions of primary antibody in
phosphate-buffered saline containing 1% (w/v) skim milk and
0.1% Tween-20, as indicated below. VP40-specific monoclonal
antibodies (MARV: anti-VP40 40-2-2 (1:2000); ZEBOV: anti-
VP40 2C4 (1:200)) were used to detect the VP40 proteins of the
respective virus. A mouse monoclonal antibody was used to detect
a-tubulin (Clone DM 1A, 1:5000; Sigma-Aldrich, St.Louis, MO,
USA) as a cellular control protein. Western blot detection was
performed with Alexa 680-conjugated anti mouse immunoglob-
ulin G secondary antibody using the Odyssey Infrared Imaging
System (LI-COR, Lincoln, NE, USA).
The total amount of protein in the cell lysates was determined
by separating cell lysates on 12% SDS polyacrylamide gels which
were stained with Coomassie Brilliant Blue. Gels were then
quantified by using the Odyssey Infrared Imaging System
Application Software (Version 2.1.12).
Rescue of recombinant Marburg virus
R06E cells were grown in 6-well plates to 50% confluence.
Transfection of plasmids coding for the supporting nucleocapsid
proteins NP (0.5 mg), VP35 (0.1 mg), VP30 (0.1 mg) and L (2 mg) as
well as the T7 polymerase (0.5 mg) and the full-length cDNA
construct of MARV (2 mg) was performed with TransIT-LT1
(Mirus, Madison, WI, USA) according to the manufacturer’s
instructions. Five hours p.t. the medium was replaced with 4 ml
DMEM with 2.5% fetal calf serum. Cells and supernatants were
harvested between day 6 and 12 after CPE formation. Superna-
tant was used to infect fresh R06E cells (passage 1). When passage
1 cells displayed a CPE, viral RNA was isolated from the
supernatant using the QIAamp Viral RNA Mini Kit (QIAGEN,
Venlo, Netherlands). One-twelfth of the eluted RNA was used for
reverse transcription-PCR (RT-PCR) using the Transkriptor One-
Step RT-PCR Kit (Roche, Basel, Switzerland) and glycoprotein-
specific primers designed to amplify nt 5889 to 7370 of the MARV
genome (forward: 59-CAGGTCGACTCAGTGAATATATTCT-
CATAT-39; reverse 59-GAGGCACCAGAACTAGAGGA). Am-
plified fragments were restricted with KpnI to distinguish
recombinant and wild type virus. Furthermore, integrity of
recombinant viral RNA was verified by sequencing of the
complete genome. Cells and supernatants of passage 1 were
inactivated by addition of 16SDS sample buffer and boiling for
10 min at 99uC. Samples were subjected to Western blot analysis
with VP40- and NP-specific monoclonal antibodies (MARV: anti-
VP40 40-2-2 (1:2000), anti-NP 59-9 (1:500); ZEBOV: anti-VP40
2C4 (1:200)).
Results and Discussion
To determine whether R06E cells are susceptible to filovirus
infections, we infected R06E and VeroE6 cells, which are
commonly used to prepare stock virus [32–34], with MARV,
strain Leiden [26], or ZEBOV, strain Mayinga using 0.5 TCID50
per cell. Both cell lines exhibited a strong cytopathic effect (CPE)
at day 7 p.i.. Supernatants of infected cells collected at day 1, 2, 3
and 7 p.i. were subjected to TCID50 analysis, which revealed that
MARV showed similar growth kinetics and end titers in R06E
cells and VeroE6 cells. ZEBOV grew faster in VeroE6 cells than in
R06E cells but reached the same maximum titer at 7 d p.i.
(Fig. 1A). When the two cell lines were infected with 5 TCID50 per
cell of EBOV or MARV no differences between R06E and
VeroE6 cells were observed (not shown). Investigations to analyze
the reason of the differences between high and low infectious doses
are underway.
The protein composition of viral particles from the supernatants
of both cell lines was analyzed by Coomassie Brilliant Blue
staining. This analysis did not show significant differences in the
viral protein composition between virus produced during infection
of R06E cells and VeroE6 cells (Fig. 1B).
Next we investigated the structure of filovirus-infected R06E
cells and viral particles, by electron microscopy (EM). Viral
inclusions in perinuclear regions were composed of hexagonally
arranged nucleocapsids with characteristic electron-transparent
internucleocapsid zones for ZEBOV (Fig. 1C 1) and a higher
density of nucleocapsid packaging for MARV (Fig. 1C 2). At the
plasma membrane, mature viral particles in the process of budding
or completely formed were readily observed (Fig. 1C 3 and 4). EM
analysis of negatively stained samples of the supernatants of R06E
cells infected with MARV or ZEBOV showed typical filamentous
particles (Fig. 1C, 5 and 6). Notably, the number of intracellular
MARV and EBOV nucleocapsids in R06E cells was considerably
higher than in VeroE6 cells. This is reflected by the larger size of
viral inclusions, which represent accumulations of viral nucleo-
capsids in R06E (Fig. 1D 3–6) compared to VeroE6 cells (Fig. 1D
1,2). We were, therefore, interested to further investigate whether
the amount of intracellular viral proteins was different in VeroE6,
HUH7 and R06E cells.
The three cell lines were infected with 0.1 TCID50 per cell and
Western blot analysis was performed with lysed cells at 48 and
72 h p.i. using monoclonal antibodies specific for MARV or
ZEBOV VP40 or the cellular cytoskeleton protein tubulin. These
analyses revealed that the fruit bat cells accumulated considerably
more viral protein than the other cell lines tested (Fig. 2A). To
further support this result, we quantified total protein levels of the
different cell lines by Coomassie staining of cell lysates separated
Figure 1. Infection of R06E cells with MARV and ZEBOV. (A) VeroE6 or R06E cells were infected with MARV or ZEBOV with 0.5 TCID50/cell.
Supernatants were collected at 1, 2, 3 and 7 days p.i. and used for TCID50 assays. (B) Supernatant from day 7 was concentrated via ultracentrifugation
and viral particles were analyzed by Coomassie staining for protein composition. (C) R06E cells were infected with MARV and ZEBOV at a high MOI,
fixed and inactivated at day 3 p.i.. Cells were dehydrated and embedded in Epon prior to ultrathin sectioning. Analysis by transmission electron
microscopy showed viral inclusions in the perinuclear region (1, 2) and mature viral particles (3, 4). MARV and ZEBOV particles were purified via
ultracentrifugation through a 20% sucrose cushion, fixed with 4% paraformaldehyde, negatively stained and analyzed by electron microscopy (5, 6).
(D) VeroE6 and R06E cells were infected with MARV and ZEBOV at a high MOI, harvested at 48 h p.i. and treated as described under B. Analysis by
transmission electron microscopy showed viral inclusions (broken lines) in the perinuclear region of VeroE6 (1, 2) and R06E (3, 4) cells at low
magnification. Higher magnification pictures of viral inclusions in R06E cells are shown under 5 and 6.
doi:10.1371/journal.pntd.0000802.g001
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Odyssey Analyzer (The 72 h gels are shown beneath the Western
blots in Fig. 2A) The amount of VP40 was then normalized against
the total cell protein (Fig. 2B). Quantification clearly shows that at
48 as well as 72 h p.i. the highest amount of viral protein can be
found in R06E cells when compared to HUH7 or VeroE6 cells
(Fig. 2B). However, our data also indicate that R06E cells support
filoviral propagation to an extent comparable with VeroE6 or
HUH7 cell lines. Furthermore, EM analysis of ultrathin sections of
R06E cells revealed morphological signs of filoviral infection
Figure 2. Expression of viral proteins in different cell lines. (A) 4610
5 HUH7, VeroE6 or R06E cells were infected with 0.1 TCID50/cell MARV or
ZEBOV. Cell lysates were prepared at 48 and 72 h p.i., subjected to Western blot analysis to detect cellular tubulin and VP40 of MARV and ZEBOV
using mouse monoclonal antibodies. The total amount of cellular proteins in the samples was quantified by separating cell lysates on SDS PAGE,
which were then stained with Coomassie Blue. Using the Odyssey Infrared Imaging Application Software, the protein signals were quantified. VP40
levels normalized to total cell protein are shown in (B).
doi:10.1371/journal.pntd.0000802.g002
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monkeys or humans [35,36] (Fig. 1C). Taken together, these
observations suggest that R06E cells may not release viral particles
with a comparable efficiency to that with which they produce
structural proteins. Further experiments to examine the viral
budding efficiency and interaction of viral proteins with proteins of
the endosomal sorting complex required for transport (ESCRT) in
fruit bat-derived cells will be very important, as it has been shown
that interaction of MARV VP40 with TSG101 or interaction of
ZEBOV VP40 with TSG101 and Nedd4 plays an important role
during the budding process [37–39].
To further investigate the suitability of R06E cells for the
analysis of filovirus replication and transcription we used artificial
filovirus minigenome systems [20,29]. Four different cell lines,
R06E, HEK293, HUH7 and VeroE6 were transfected with
plasmids encoding a MARV minigenome and the viral proteins
necessary for replication and transcription (NP, VP35, VP30 and
L). Cell lysates were analyzed 48 h p.t. for luciferase reporter
activity. All analyzed cell lines showed nearly the same reporter
activity, except for the fruit bat cell line where activity was slightly
decreased (Fig. 3A, upper panel). Using a plasmid encoding the
green fluorescence protein (GFP) for transfection of cells we found
that the transfection efficiency was 15% for R06E cells, 50% for
HEK293, 38% for HUH7 and 27% for VeroE6 cells (data not
shown). When the transfection efficiency was taken into account,
reporter signal in all tested cell lines showed no significant
differences (Fig. 3A, lower panel). Furthermore we have tested the
Ebola virus minigenome system with R06E, HUH7, VeroE6 and
293 cells and got comparable reporter gene activity (data not
shown).
It was then investigated whether it was possible to produce
MARV infectious virus-like particles (iVLPs) in R06E cells [30]
and to establish a naı ¨ve iVLP assay for MARV to investigate
primary transcription, as has already been described for ZEBOV
[31]. R06E or HEK293 cells (producer cells, pc) were transfected
with plasmids encoding all MARV structural proteins, the
minigenome and the T7 support plasmid [30]. At 48 h p.t., cells
and supernatants were harvested and iVLPs from the supernatant
were used to infect HUH7 or R06E cells (indicator cells, ic), which
were either untreated or pretransfected with plasmids encoding the
nucleocapsid proteins. We did not detect a significant difference in
the luciferase reporter signal in ic, when these were pretransfected
(Fig. 3B). Interestingly, when non-transfected ic (naı ¨ve) were
infected with iVLPs, only R06E cells showed reporter gene signals
(Fig. 3C). Further experiments with the naı ¨ve iVLP assay revealed
that using HEK293 cells to produce the iVLPs (pc) and R06E cells
as ic produced the highest reporter gene signals in the indicator
Figure 3. MARV-specific in vitro assays. (A) Minigenome assay.
Different cell lines were transfected with all of the plasmids necessary
for replication and transcription of a MARV (3M–5M) minigenome.
Relative light units (RLU) represent the efficiency of replication and
transcription of the minigenome (upper panel). This experiment was
performed in triplicate and standard deviations are shown. Asterisks
indicate statistically significant differences (*** P-value#0.002) RLUs
shown in the upper panel were normalized to the transfection
efficiency of the cells, as analyzed by a GFP-reporter construct. (lower
panel) (B) iVLP assay with pretransfected indicator cells. HEK293 or R06E
cells were transfected with all of the plasmids necessary to produce
MARV iVLPs (producer cells, pc). Supernatants were collected 72 h p.t.
and used to infect new indicator cells (HUH7 or R06E cells)
pretransfected with all of the plasmids necessary for replication and
transcription (indicator cells, ic). Three days p.i. the luciferase activity in
the ic was determined, reflecting iVLP formation, budding, iVLP entry,
minigenome delivery and secondary transcription. (C) iVLP assay with
naı ¨ve indicator cells. R06E cells were transfected with all of the plasmids
necessary to produce iVLPs (pc). Supernatant was collected 72 h p.t.
and used to infect R06E cells that were not pretransfected. Luciferase
activity in the indicator cells was determined 48 or 72 h p.i., reflecting
iVLP formation, budding, iVLP entry, minigenome delivery and primary
transcription of minigenomes. This experiment was performed in
triplicate and standard deviations are shown.
doi:10.1371/journal.pntd.0000802.g003
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very high transfection efficiency of HEK293 cells for iVLP
production and the high capacity for efficient production of viral
proteins in R06E cells.
It was then investigated whether recombinant MARV could be
rescued from R06E cells. Previous attempts using the experimental
set-up described by Enterlein et al. had not worked in our hands
[40]. Finally, after having unsuccessfully tested several combina-
tions of cell lines for transfection and passage of potentially rescued
virus, we used R06E cells for transfection of plasmids encoding the
MARV nucleocapsid proteins as well as the T7 polymerase
together with the plasmid containing the full length genome of
MARV under the control of the T7 promoter. After 6–12 days
cells and supernatant were harvested. The supernatant was used to
infect fresh R06E cells (passage 1). This method allowed us to
rescue three different recombinant viruses of which rescue of clone
#16 is shown in Fig. 4. In the transfected cells, CPE formation was
visible at day 7 p.t. and at day 8 after passaging the supernatant to
fresh cells. At this time, RNA was purified from supernatant and
RT-PCR was performed with GP-specific primers. The amplified
fragments were restricted with KpnI, the restriction site for which
was mutated in the recombinant full-length genome. Agarose gel
electrophoresis of the fragments showed that, while control PCR
fragments derived from the wild-type MARV genome were
restricted by KpnI, fragments from clone #16 were not, indicating
that clone #16 was a recombinant virus. In addition, Western blot
analyses with VP40- and NP-specific monoclonal antibodies were
performed to confirm the presence of recombinant virus in the
supernatant. Taken together, our experiments suggest that the
efficient rescue in R06E cells is the result of an exceptional support
of MARV replication in the fruit bat cell line. This observation is
consistent with the highly efficient expression of MARV proteins
in R06E cells and their ability to release high titers of MARV in
the supernatant.
At first glance the high expression levels of viral proteins and
high viral titers found in the supernatants of the fruit bat-derived
cell line R06E are puzzling in light of the presumption that
Rousettus aegyptiacus is a reservoir for filoviruses. However,
experimental infection of fruit bats with ZEBOV has been shown
to result in productive infection and high titers of virus without
clear signs of illness in the infected animals [16]. A more recent
study described a similar observation in the reservoir fruit bat of
Nipah virus. In this study Nipah virus-infected Pteropus bats
developed a subclinical infection, neutralizing antibodies were
Figure 4. Rescue of recombinant MARV from R06E cells. R06E cells were transfected with all the plasmids sufficient for replication and
transcription, a T7 polymerase construct and a T7-driven full-length cDNA construct of MARV (clone #16). (A) CPE formation was monitored at day 7
post transfection (p.t.). (B) Supernatant of transfected cells collected on day 7 was used to infect fresh VeroE6 cells (passage 1, p1). CPE formation was
monitored 8 days post infection. (C) Supernatant of p1 was collected on day 8 p.i. and viral RNA was extracted. Glycoprotein gene-specific RT-PCR and
subsequent restriction of the DNA with KpnI, a restriction site present only in the wild type genome, revealed the rescue of recombinant virus. (D) On
day 8 p.i. supernatant and cells were lysed and subjected to Western blot analysis using monoclonal antibodies to detect the MARV proteins NP and
VP40. * unknown cellular protein.
doi:10.1371/journal.pntd.0000802.g004
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periodically [41]. While the mechanisms that result in persistence
of filoviruses in the natural host are not understood, it is possible
that the huge amounts of viral protein produced by primary target
cells induce a rapid immune response leading to clearance of the
virus from circulation, with the exception of tissues that are less
accessible to the immune response. For filoviruses it has been
shown that in the course of human infection, infectious virus
continues to be detected in the semen for more than 80 days after
infection and can lead to sexually transmitted disease as was the
case for Marburg virus [42,43]. It is therefore of interest to
investigate whether hidden repositories of virus are present within
infected Rousettus aegyptiacus that are then reactivated under certain
unknown conditions. In addition, using the R06E cells, it will be of
great interest to investigate how the bats interferon system
responds to filovirus infection. Studies are underway to explore
whether filoviruses are able to induce a persistent infection in
R06E cells and to further analyze the innate immune response of
the cells to infection with filoviruses.
In summary, we were able to show that R06E cells can be
infected productively with filoviruses, giving rise to infectious viral
particles. Infected cells show morphological signs of filoviral
infection similar to those detected previously in cells originating
from monkeys or humans. Further, R06E cells seem to be more
effective in producing recombinant MARV than other cell lines
tested and allowed for the establishment of a naı ¨ve infectious VLP
assay for MARV. These results emphasize the suitability of the
newly established bat cell line for further research in numerous
areas of filovirus biology.
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